Martin Illemann - Recent Publications

W Alpízar-Alpízar, IJ Christensen, E Santoni-Rugiu A Skarstein, K Ovrebo, M Illemann, and OD Lærum:
Urokinase plasminogen activation receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma.
Int. J. Cancer, Epub ahead of print Sep 7th.

T Thurison, IK Lund, M Illemann, IJ Christensen, and G Høyer-Hansen:
Urokinase-type plasminogen activator, its receptor and inhibitor as biomarkers in cancer.
In Matrix Proteases in Health and Disease. Ed. N Behrendt. Wiley-VCH STM-Books, Germany. Accepted for publication August 15th, 2011.

OD Lærum, K Ovrebo, A Skarstein, IJ Christensen, W Alpízar-Alpízar, L Helgeland, K Danø, BS Nielsen, and M Illemann:
Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia can be directly evaluated by immunohistochemistry of uPAR.
Int. J. Cancer, Epub ahead of print Aug 22nd, 2011.

IK Lund, BS Nielsen, K Almholt, B Rønø, A Hald, M Illemann, KA Green, IJ Christensen, J Rømer, and LR Lund:
Concomitant lack of MMP9 and uPA disturbs physiological tissue remodelling.
Dev Biol.. Epub ahead of print. June 22nd, 2011.

IK Lund, M Illemann, T Thurison, IJ Christensen, and G Høyer-Hansen:
uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy.
Curr. Drug Target. Epub ahead of print. June 27th, 2011.

B Jacobsen, E Santoni-Rugiu, M Illemann, OD Lærum, and M Ploug:
Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma.
Int. J. Cancer. Epub ahead of print. July 22nd, 2011.

Morten G. Rasch, Ida K. Lund, Martin Illemann, Gunilla Høyer-Hansen, and Henrik Gårdsvoll:
Purification and characterization of recombinant full-length and protease-domain of murine MMP-9 in Drosophila S2 cells.
Protein Expression and Purification. 2010. 72: 87-94.

Alpízar-Alpízar, W., Nielsen, B.S., Sierra, R., Illemann, M., Rakárez, J.A., Arias, A., Durán, S., Lund, L.R. and Laerum, O.D.:
Urokinase plasminogen activator receptor (uPAR) expression in gastric carcinomas from high and low risk countries.
Int J Cancer. 2010, 126:405-415.

Alpízar-Alpízar, W., Laerum, O.D., Illemann, M., Ramírez, J.A., Arias, A., Malespín-Bendaña, W., Ramírez, V., Lund, L.R., Borregaard, N., Nielsen, B.S.:
Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori.
Virchows Arch. 2009, 455:225–233.

Illemann, M., Bird, N., Majeed, A., Lærum, O.D., Lund, L.R., Danø, K. and Nielsen, B.S.:
"Two Distinct Expession Patterns of Urokinase, Urokinase Receptor and Plasminogen Activator Inhibitor-1 in Colon Cancer Liver Metastases."
International Journal of Cancer. 2009, 124: 1860-1870.

Laerum, O.D., Illemann, M., Skarstein, A., Helgeland, L., Øvrebø, K., Danø, K. and Nielsen, B.S.:
Crohn’s disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons.
Amer J Gastroenterol. 2008, 103: 2350-2358.

Rasch, M.G., Pass, J.Illemann, M., Høyer-Hansen, G. and Lund, I.K.:
"Discrimination of different forms of the murine urokinase receptor on the cell surface using monoclonal antibodies."
J. Immunol. Meth. 2008, 339: 55-65.

Hansen, L.V., Laerum, O.D., Illemann, M., Nielsen, B.S. and Danø, K.:
"Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma."
Int. J. Cancer. 2008, 122: 734-741.

Nielsen, B.S., Rank, F., Illemann, M., Lund, L.R. and Danø, K.:
"Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor."
Int. J. Cancer. 2007, 120: 2086-2095.

Illemann, M., Bird, N., Majeed, A., Sehested, M., Laerum, O.D., Lund, L.R., Danø, K. and Nielsen, B.S.:
"MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases."
Mol Cancer Res. 2006, 4: 293-302.

Holten-Andersen, M.N., Hansen, U., Brünner, N., Nielsen, H.J., Illemann, M. and Nielsen, B.S.:
"Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenomcarcinoma."
Int. J. Cancer. 2005, 113: 198-206.

Illemann, M., Hansen, U., Nielsen, H.J., Andreasen, P.A., Høyer-Hansen, G., Lund, L.R., Danø, K. and Nielsen, B.S.:
"Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1."
Am J Clin Pathol. 2004, 122: 256-265.